Tuesday, 04 Nov 2025

MedPulse360

AP-101 Meets Primary End Point in Phase 2 Study of SOD1 ALS
14 September, 2025

Expanding the Future of Pediatric Migraine Care With Novel Pathways: Patricia Pozo-Rosich, MD, PhD
14 September, 2025

Identifying Gaps in Lennox-Gastaut Syndrome Care Across the Lifespan
14 September, 2025

Personalized Extended Interval Dosing Reduces John Cunningham Virus Seroconversion Rate for Natalizumab
14 September, 2025

NeurologyLive® Friday 5 — September 5, 2025
14 September, 2025

Episode 149: Overviewing Consensus Guidelines to Standardize Gene Therapy Care in Duchenne
14 September, 2025

Investigational BAT4406F Performs in Phase 2/3 Study of NMOSD, Leading to Early Enrollment Termination
14 September, 2025

Post-AAIC 2025 Perspective on Advances in Alzheimer Diagnosis and Treatment: Rebecca M. Edelmayer, PhD
14 September, 2025

Overviewing Phase 1/2 PACIFIC Trial of Bexicaserin in Developmental Epileptic Encephalopathies: Ingrid Scheffer, AO, PhD, FRACP, FAHMS, FAA
14 September, 2025

Digital Lifestyle App Levidex Fails to Meet Primary End Point for Early MS in POWER@MS1 Trial
14 September, 2025
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago